Position in SCLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,628
-$155 QoQ
Shares Held
1,596
+80.5% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026ROYAL BANK OF CANADA holds $17,384,844,445 across 18 Drug Manufacturers - General names. SCLX ranks #18 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,262,531 | $3,920,548,130 | |
| 2 | JNJ |
Johnson & Johnson
|
13,387,402 | $3,272,416,535 | |
| 3 | AZN |
Astrazeneca PLC
|
10,386,455 | $2,048,416,647 | |
| 4 | ABBV |
AbbVie Inc.
|
7,534,148 | $1,638,601,840 | |
| 5 | MRK |
Merck & Co., Inc.
|
13,201,722 | $1,588,035,133 | |
| 6 | AMGN |
Amgen Inc
|
4,471,445 | $1,573,277,917 | |
| 7 | PFE |
Pfizer Inc
|
34,155,840 | $959,095,979 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
5,647,122 | $787,039,387 |
All Filings in SCLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,628 | 1,596 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,783 | 884 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,852 | 145 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,399 | 917 | Shares | Defined | 2025-11-21 | |
| No filing history on record for this holder in this stock. | ||||||